Skip to main content
. 2000 Feb 5;2(3):158–169. doi: 10.1186/bcr49

Table 1.

Summary of homeobox gene expression and function in mammary gland development and neoplasia

Gene Gene Expression Expression altered in Mammary or in vitro
family namea detected inb: Methodc neoplasias ? Possible regulation? phenotype? Reference
Hox/HOX Hoxa-1 MG (UD) RT-PCR; Northern OE (freq.) Extracellular matrix [31*,33*]
Scp2, CID-9 components
HOXA-1 MCF7 RT-PCR Retinoic acid [63,30]
Hoxa-5 CID-9 RT-PCR [33*]
Hoxa-7 MG RT-PCR [31*]
HOXA-7 MG RT-PCR 1
Hoxa-9 MG RT-PCR KO: lactational defects [38*]
HOXA-10 MCF7 RT-PCR Vitamin D OE in MCF7: promotes cell cycle [30,64]
arrest at G1
Hoxb-6 MG RT-PCR; Northern Lost [31*]
HOXB-6 MCF7 RT-PCR [30]
Hoxb-7 MG (E+S) Northern; in situ UE Extracellular matrix OE in SkBr3 cells: bFGF induction; [33*,57]
components; developmental increased proliferation; decreased
growth factor dependency
Hoxb-8 CID-9 RT-PCR [33*]
Hoxb-9 CID-9 E12.5 RT-PCR; in situ KO: lactational defects [33*,38]
Embryo (MM)
Hoxc-6 MG Northern Lost Estrogen (-); developmental [31]
HOXC-6 MCF7; MCF7D; cDNA screen; Variable [57,65]
Hs578Bst; RT-PCR
MCF10F; T47D
Hoxc-8 MG Northern Lost Estrogen (-); developmental [32]
HOXC-10 MG PCR of cDNA library 2
Hoxd-3 MG (UD) Northern OE (rarely) [32]
Hoxd-4 MG (E) In situ Lost [32]
Hoxd-8 MG Northern Lost Developmental [32]
Hoxd-9 MG (E+S); RT-PCR; Lost Developmental KO: lactational defects [32,38]
E12.5 Embryo Northern; in situ
(MM)
Hoxd-10 MG (E+S) Northern; in situ Lost Developmental KO: lactational defects [32,39];2
Hoxd-11 MG (UD) Northern No [32]
Hord-12 MG RT-PCR; OE (myc tumor) [31*]
Northern (UD)
Msx Msx-1 E13.5 Embryo (E); Northern; in situ Maintained but variable Developmental KO: none detected in embryos [40*,41*]
MG (E)
Msx-2 E13.5 Embryo (E); Northern; in situ Lost Estrogen; developmental KO: MG fail to form [40*];3
MG (S)
Iroquois related IRX-1 MG RT-PCR [48*]
IRx-2 MG; primary RT-PCR; Northern; Maintained, expression Developmental [48*]
tumors in situ levels or splice form
usage may be altered
in some tumors
IRX-3 MG RT-PCR [48*]
IRX-4 MG RT-PCR [48*]
IRX-5 MG RT-PCR [48*]
Paired domain Alx-4 MG(S) In situ Expression associated with KO: none detected [45]
actively condensing periductal
stroma
HSIX HSIX-1 MCF7 OE Expressed in S phase OE in MCF7 abolishes X-ray induced [58*]
of cell cycle cell cycle arrest in G2 phase
POU domain OCT-1 MCF7; MCF10; RT-PCR; [54]
SkBr3;MDA- Western EMSA
MB453
Oct-1 MG (lact.) RT-PCR [53]
OCT-2 MCF7; MCF10;
SkBr3 RT-PCR; [54]
Western EMSA
OCT-3 MG (UD); MCF7; RT-PCR OE (freq.) Form with a 5 amino acid deletion [54]
MCF10; SkBr3; detected om MCF7 cell
primary tumors
Oct-3 MG (lact.) RT-PCR [53]
OCT-11 MG (UD) MCF7; RT-PCR; EMSA OE (freq.) [54]
skBr3; MDA-
MB453; primary
tumors
Pit-rs 1 MG (lact.) RT-PCR [53]
Pou4f1 = Brn-3 MG (lact.) RT-PCR [53]
Pou4f-rs1 = MG (lact.) RT-PCR [53]
Brn-3R
Pou3f4 = Brn-4 MG (lact.) RT-PCR [53]
Pou3f-rs1 = MG (lact.) RT-PCR [53]
POU-IIIA
Engrailed related En-1 MG Northern UE (freq.) Developmental [32]
En-2 MG (UD) Northern UD KO: none detechted [32]
MOX MOX1 MG [52]
MEIS MEIS2a MG RT-PCR of cDNA library 4
MEIS 2d MG RT-PCR of cDNA library 4
MRG1a MG RT-PCR of cDNA library 4

bFGF, basic fibroblast growth factor; E, epithelium; EMSA, electrophoretic mobility shift assay; freq., frequently; KO, knockout mutation; lact., lactating; M, mammary mesenchyme; MG mammary gland; Northern, Northern blot assay; OE, overexpressed; RT-PCR, reverse transcriptase polymerase chain rection; S, periductal stroma; UD, undetectable; UE, underexpressed. aHuman genes are uppercase; mouse genes are lowercase. bCalle lines are listed by their common designation. If expression was detected in the intact mammary gland, the tissue compartment is shown. cNot all detection techniques have been used on all tissue types/cell lines shown. 1Friedmann Y, Daniel CW, unpublished results; 2Lewis MT, Daniel CW, unpublished results; 3Maas R, unpublished results, cited in [41]; 4Lewis MT, unpublished results.